BioXcel Therapeutics, Inc. (Nasdaq: BTAI), a biopharmaceutical company utilizing artificial intelligence to develop ...

ZK International Group Co., Ltd. (Nasdaq: ZKIN) ("ZK International" or the "Company"), a leading engineering Company focused on high-performance steel products, announces a 1-for-7 reverse split of ...

Detailed price information for Tonix Pharm Holdings (TNXP-Q) from The Globe and Mail including charting and trades.

ZK International Group (NASDAQ:ZKIN) on Wednesday announced a 1-for-7 reverse split of ... reflecting the reverse stock split, under the existing symbol "ZKIN". Upon effectiveness of the split ...

under the exiting symbol "ZKIN". The new CUSIP number for the ordinary shares following the reverse stock split will be G9892K209. Upon effectiveness of the reverse stock split, every 7 shares of ...

CHATHAM, N.J. - Tonix Pharmaceuticals Holding Corp. (NASDAQ:TNXP), a biopharmaceutical company, has announced a 1-for-100 reverse stock split of its common stock, set to take effect as trading opens ...

under the exiting symbol "ZKIN". The new CUSIP number for the ordinary shares following the reverse stock split will be G9892K209. Upon effectiveness of the reverse stock split, every 7 shares of the ...

The Board of Directors approved the reverse stock split proposal at the Company's Board Meeting held on August 7, 2024 ... to trade on Nasdaq under the symbol "FCUV" but will trade under a ...